A Phase I/II, Open Label, Controlled Study to Evaluate the Safety and Efficacy of AppliGel-G [Gentamicin Sulfate Topical Gel] for Treatment of Mild to Moderately Infected Diabetic Foot Ulcers in Patients With Type 1 and Type 2 Diabetes

Trial Profile

A Phase I/II, Open Label, Controlled Study to Evaluate the Safety and Efficacy of AppliGel-G [Gentamicin Sulfate Topical Gel] for Treatment of Mild to Moderately Infected Diabetic Foot Ulcers in Patients With Type 1 and Type 2 Diabetes

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 18 May 2015

At a glance

  • Drugs Gentamicin (Primary) ; Ciprofloxacin; Doxycycline
  • Indications Bacterial skin diseases; Diabetic foot ulcer
  • Focus Therapeutic Use
  • Sponsors Royer Biomedical
  • Most Recent Events

    • 13 May 2015 Status changed from recruiting to discontinued as per ClinicalTrials.gov record
    • 12 Feb 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top